| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 10/15/2008 | CN101284079A Chinese medicinal composition for curing the impotence and impairment of qi and blood |
| 10/15/2008 | CN101284065A Chinese medicinal composition for treating the prostatitis and preparation method thereof |
| 10/15/2008 | CN101284059A Chinese medicinal materials preparation for reinforcing the spleen and kidney and curing the chronic nephritis |
| 10/15/2008 | CN101283995A Different pharmaceutical uses alpha2delta ligands |
| 10/15/2008 | CN101283968A Tolterodine fumarate oral solid preparation and preparation method thereof |
| 10/15/2008 | CN101283721A Concentrated coffee pulp |
| 10/15/2008 | CN100425608C Acyloxypyrrolidine derivatives, preparation thereof and application thereof in therapeutic |
| 10/15/2008 | CN100425271C Detoxicating and kidney defending clyster powder |
| 10/15/2008 | CN100425262C Medicine for treating urinary incontinence and its preparing process |
| 10/14/2008 | US7435742 potent antagonists of M3 muscarinic receptors; chronic obstructive pulmonary disease; bronchitis, bronchial hyperreactivity, asthma, cough and rhinitis; gastrointestinal disorders; incontinenc; [2-(3,4-Dimethoxyphenyl)ethyl]-(5-methylfuran-2-ylmethyl)carbamic acid (3R)-1 -azabicyclo[2.2.2]oct-3-yl ester |
| 10/14/2008 | US7435737 4-(1-Piperazinyl)-2(1H)-quinolone and 4-(1-piperazinyl)quinoline derivatives, e.g., 3-nitro- or 3-alkoxycarbonyl-1-methyl-4-[4-thiophene-2-carbonyl)-piperazine-1-yl]-1H-quinolin-2-one; antitumor and angiogenesis inhibitor, antiinflammatory, antidiabetic agent, autoimmune disorder |
| 10/14/2008 | US7435729 using estrogen antagonist ; anticancer agents |
| 10/14/2008 | CA2384331C The use of halofuginone and related compounds for the treatment of urethral stricture by local administration |
| 10/14/2008 | CA2309328C Cyclic amine derivatives and their use as drugs |
| 10/09/2008 | WO2008121893A1 Methods of treating heart failure and renal dysfunction in individuals with an adenosine a1 receptor antagonist |
| 10/09/2008 | WO2008121882A1 Improved methods of administration of adenosine a1 receptor antagonists |
| 10/09/2008 | WO2008120761A1 Heteroaryl derivative |
| 10/09/2008 | WO2008120725A1 Novel pyrrolinone derivative and medicinal composition containing the same |
| 10/09/2008 | WO2008120653A1 Indoledione derivative |
| 10/09/2008 | WO2008120206A1 Water soluble opuntia extracts for the inhibition of alpha-1-adrenergic receptors |
| 10/09/2008 | WO2008119772A1 Amide derivatives as inhibitors of aspartyl proteases |
| 10/09/2008 | WO2008070778A3 Pyridoxamine and low molecular weight heparinoids for diabetic kidney disease |
| 10/09/2008 | WO2007092721A8 Vitamin d analog: rak, methods and uses thereof |
| 10/09/2008 | WO2006074117A3 Silver/water, silver gels and silver-based compositions; and methods for making and using the same |
| 10/09/2008 | US20080249177 Selective beta 3-adrenoceptor stimulants; obesity, diabetes mellitus, hyperlipidemia, pollakiuria, urinary incontinence, intestinal hypermotility; e.g. 4'-{2-[(1S,2R)-2-hydroxy-2-(4-hydroxyphenyl)-1-methyl ethylamino]ethoxy}-2,3',5'-trimethylbiphenyl-4-carboxylic acid |
| 10/09/2008 | US20080249154 Preventive and/or Therapeutic Agent For Disease In Which Mitochondrial Benzodiazephine Receptor Participates |
| 10/09/2008 | US20080249147 Emulsion-Stabilized Preparation |
| 10/09/2008 | US20080249138 Pyridine Compounds For The Treatment Of Prostaglandin Mediated Diseases |
| 10/09/2008 | US20080249114 Beta-3 adrenergic receptor agonists; urinary tract infections, incontinence, gastrointestinal disorders, dysmenorrhea, obesity; tocolytic, anxiolytic, antidiabetic agents; antidepressants; 4-(2-hydroxy-3-(1-(5-phenylthieno[2,3-d]pyrimidin-4-yl)piperidin-4-ylamino)propoxy)phenol |
| 10/09/2008 | US20080249098 peripheral benzodiazepine receptors; 7-fluoro-N,N,5-trimethyl-4-oxo-3-(pyridin-2-yl)-3,5-dihydro-4H-pyridazino[4,5-b]indole-1-carboxamide; for the treatment of various types of peripheral neuropathies, amyotrophic lateral sclerosis |
| 10/09/2008 | US20080249009 ApM-1 and related proteins to influence partitioning of dietary lipids between liver and peripheral tissues; reduce free fatty acids in obese individuals; decrease body weight; atherosclerosis; insulin resistance; hypertension, microangiopathic lesions |
| 10/09/2008 | CA2683938A1 Water soluble opuntia extracts for the inhibition of alpha-1-adrenergic receptors |
| 10/09/2008 | CA2682727A1 Indoledione derivative |
| 10/09/2008 | CA2682473A1 Novel pyrrolinone derivative and pharmaceutical composition comprising the same |
| 10/09/2008 | CA2682377A1 Heteroaryl derivatives |
| 10/08/2008 | EP1978096A1 Novel oligonucleotide and nf-kappa b decoy comprising the same |
| 10/08/2008 | EP1978034A1 Anti-periostin antibody and pharmaceutical composition for preventing or treating periostin-related disease containing the same |
| 10/08/2008 | EP1977762A1 Ctgf as target for the therapy of diabetic nephropathy |
| 10/08/2008 | EP1977745A1 Method for the treatment of incontinence |
| 10/08/2008 | EP1977742A1 Preventive/remedy for urinary calculosis |
| 10/08/2008 | EP1977741A2 Use of renin inhibitors in therapy |
| 10/08/2008 | EP1977738A1 Pharmaceutical compositions comprising atorvastatin manufactured without granulation |
| 10/08/2008 | EP1977249A2 Method of diagnosis and method of treatment |
| 10/08/2008 | EP1755634B1 Oligopeptides for reducing elevated blood urea concentration |
| 10/08/2008 | EP1646390B1 A1 adenosine receptor antagonists |
| 10/08/2008 | EP1539693B9 Cannabinoid receptor agonists |
| 10/08/2008 | EP1379246B1 Nociceptin analogs |
| 10/08/2008 | EP1032667B1 Platelet specific antigens and their pharmacological uses |
| 10/08/2008 | CN101280264A Sheep kidney wine capable of preventing kidney deficiency strain and lumbar vertebrae pain |
| 10/08/2008 | CN101279971A 4,4-difluoro-1,2,3,4-tetrahydro-5h-1-benzoazepine derivative or salt of the same |
| 10/08/2008 | CN101279092A Applications of VEGF receptor fusion protein in preparation of medicament for curing diseases about angiogenesis |
| 10/08/2008 | CN101279015A Chinese medicinal composition for curing bed-wetting and method of preparing the same |
| 10/08/2008 | CN101279010A Guilu erxian paste for curing hyperplasia of prostate gland |
| 10/08/2008 | CN101279007A Chinese medicine for curing aconuresis |
| 10/08/2008 | CN101278987A Chinese medicine compound for nourishing yin and tonifying kidney, benefiting-qi and promoting blood circulation, enriching blood and benefiting semen |
| 10/08/2008 | CN100423777C Glycoprotein compositions |
| 10/08/2008 | CN100423716C Modafinil pharmaceutical compositions |
| 10/07/2008 | US7433788 Crystallization of IGF-1 |
| 10/07/2008 | US7432374 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 10/07/2008 | US7432364 Polynucleotide which encodes human antibody that binds to tissue inhibitors of metalloproteases; used to diagnose and treat liver & cardiac fibrosis, alcoholic liver disease, acute coronary syndrome, lupus nephritis, glomerulosclerotic renal disease, benign prostate hypertrophy, colon and lung cancer |
| 10/07/2008 | US7432356 Complement pathway inhibitors binding to C5 and C5a without preventing formation of C5b |
| 10/07/2008 | US7432299 Use of alpha-2-delta ligands such as gabapentin, pregabalin and other alpha-2-delta ligands such as [6-(Aminomethyl)bicyclo[3.2.0]hept-6-yl]acetic acid; treatment of premature ejaculation |
| 10/07/2008 | US7432296 Pharmaceutical formulations containing substituted 2-aryl-aminoacetic acid compounds and/or substituted 2-heteroaryl-aminoacetic acid compounds |
| 10/07/2008 | US7432289 5-Acylamino-1,1′-biphenyl-4-carboxamide derivatives and their use as P38 kinase inhibitors |
| 10/07/2008 | US7432285 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use |
| 10/07/2008 | US7432270 N-aroyl cyclic amines |
| 10/07/2008 | US7432268 17β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases |
| 10/07/2008 | US7432263 Amino-phthalazinone derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them |
| 10/07/2008 | US7432240 Fumaric acid amides |
| 10/07/2008 | CA2427573C Indole derivatives as pde5-inhibitors |
| 10/07/2008 | CA2426009C Cholesterol lowering benzo[b]thiophenes and benzo[d]isothiazoles |
| 10/07/2008 | CA2411544C N-alkyl-adamantyl triazinyl benzamide derivatives |
| 10/07/2008 | CA2225022C New polymorphous form of doxazosine mesylate (form iii) |
| 10/07/2008 | CA2106061C Human follicle stimulating hormone receptor |
| 10/02/2008 | WO2008118148A2 Adiponectin for the treatment and diagnosis of albuminuria |
| 10/02/2008 | WO2008117862A1 Novel (2-aminophenyl)pyridinecarboxamide derivative having urea structure |
| 10/02/2008 | WO2008117815A1 Inhibitor for cell death caused by endoplasmic reticulum stress or oxidation stress |
| 10/02/2008 | WO2008117790A1 Food/beverage and pharmaceutical composition for oral administration for improvement in acidic urine each comprising fucoidan as active ingredient |
| 10/02/2008 | WO2008117229A1 Muscarinic receptor antagonists |
| 10/02/2008 | WO2008116262A1 Methods and compositions for treating prostate cancer |
| 10/02/2008 | WO2008032054A3 Composite material comprising a tissue matrix compound and a bioactive glass |
| 10/02/2008 | US20080242741 Intranasal drug delivery system |
| 10/02/2008 | US20080242716 Ion Channel Modulators |
| 10/02/2008 | US20080242674 Medicine For Prevention or Treatment of Frequent Urination or Urinary Incontinence |
| 10/02/2008 | US20080242669 compounds which mimic the secondary structure of alpha -helix regions of biologically active peptides and proteins; compounds are used to reverse fibrotic conditions |
| 10/02/2008 | US20080241961 Drosophila g protein coupled receptors, nucleic acids, and mehtods related to the same |
| 10/02/2008 | US20080241960 Insulin-like growth factor binding protein specific monoclonal antibody for use in diagnosis, prevention and treatment of cell proliferative, inflammatory, autoimmune, muscular and vision disorders |
| 10/02/2008 | US20080241946 Kit which determines concentration of phosphate metabolizing protein and utilizes profile as indicator of hypo/hyperphosphatemic disorders |
| 10/02/2008 | US20080241158 G-protein coupled receptors for use in identifying modulators for treatment and prevention of cell proliferative, neurological, cardiovascular, gastrointestinal, autoimmune/inflammatory, metabolic and viral disorders |
| 10/02/2008 | US20080241152 Vascular Endothelial Growth Factor C (VEGF-C) Protein and Gene, Mutants Thereof, and Uses Thereof |
| 10/02/2008 | US20080241143 Using selectin therapeutic in treatment of inflammatory bowel and joint disorders |
| 10/02/2008 | US20080241134 Uses of human monoclonal antibodies against oxidized ldl receptor |
| 10/02/2008 | US20080241112 Therapy of Kidney Diseases and Multiorgan Failure with Mesenchymal Stem Cells and Mesenchymal Stem Cell Conditioned Media |
| 10/02/2008 | US20080241077 Benzoylguanidine salt and hydrates thereof |
| 10/02/2008 | CA2681917A1 Methods and compositions for treating prostate cancer |
| 10/02/2008 | CA2680517A1 Novel pyridinecarboxylic acid (2-aminophenyl)amide derivative having urea structure |
| 10/02/2008 | CA2583658A1 Multi-carotenoids compositions and uses therefor |
| 10/01/2008 | EP1975164A2 Octahydrobenzimidazolone compounds as analgetics |
| 10/01/2008 | EP1974725A1 Sustained release preparation and method for production thereof |
| 10/01/2008 | EP1496877B1 Method and composition for treatment of diabetes, hypertension, chronic heart failure and fluid retentive states |